Orphenadrine Citrate Injection Shortage
Last Updated: August 14, 2023
Status: Current
Products Affected - Description
-
- Orphenadrine Citrate solution for injection, Akorn, 30 mg/mL, 2 mL vial, 10 count, NDC 17478-0538-02 - discontinued
Reason for the Shortage
-
- Akorn ceased operations in February 2023.
- Hikma did not provide a reason for the shortage.
Available Products
-
- Orphenadrine Citrate solution for injection, Hikma, 30 mg/mL, 2 mL vial, 10 count, NDC 00641-6182-10
Estimated Resupply Dates
-
- Hikma has orphenadrine citrate 30 mg/mL 2 mL vials available.
Updated
Updated August 14, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 21, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.